Skip to main content

Table 2 Incidence of renal cell carcinoma which subgroup analyzed by transplant type, region and research type

From: Incidence of renal cell carcinoma after solid organ transplantation: a systematic review and meta-analysis

Transplant type

Study(patients)

SIR(95%CI)

Heterogeneity

Meta-regression

Publication bias

Grade

Liver Transplantation

      

Total

11(57,118)

0.73 (0.53, 0.93)*

0.594, 0.0%

 

0.876, 0.036¶

Low

Geographic location

      

Europe

6(12,247)

0.91(0.50, 1.32)*

0.906, 0.0%

0.945

0.851, 0.784

Moderate

Asia

4(42,837)

0.93(0.27,1.59)*

0.158,42.2%

 

0.497, 0.353

Moderate

North America

1(2034)

1.13(-0.01, 2.28)

-

  

-

Research type

      

Retrospective study

6(46,117)

1.89(1.46, 2.31)*

0.767,0.0%

0.561

0.851, 0.218

Moderate

Cohort study

5(11,001)

2.07(0.88, 3.26)*

0.861,0.0%

 

0.624, 0.270

Moderate

Kidney Transplantation

      

Total

11(173,872)

8.54(6.68, 10.40)*

0.000,90.0%#

 

0.881, 0.393

Low

Geographic location

      

Europe

6(48,726)

6.43(4.55, 8.31)*

0.000,82.2%#

0.285

0.348, 0.805

Low

Asia

3(112,587)

18.50(4.33, 32.68)*

0.000,97.1%#

 

0.602, 0.508

Low

North America

2(12,559)

11.57(-0.19,23.33)

0.085,66.3%#

 

0.317,-

Very low

Research type

      

Retrospective study

6(120,887)

11.85(7.82,15.89)*

0.000, 94.2%#

0.519

0.573, 0.468

Low

Cohort study

5(52,985)

6.83(5.23, 8.43)*

0.008, 71.0%#

 

0.624, 0.654

Low

Heart Transplantation

      

Total

6(24,102)

3.37(2.02, 4.71)*

0.209, 30.2%

 

0.748, 0.276

Moderate

Geographic location

      

Europe

4(5434)

4.17(1.49, 6.85)*

0.119, 48.7%

0.047&

1.000, 0.798

Moderate

Asia

2(18,668)

2.89(2.26, 3.53)*

0.834, 0.0%

 

0.317,-

Low

Research type

      

Retrospective study

4(19,481)

3.93(1.58, 6.28)*

0.237, 29.2%

0.842

1.000, 0.389

Moderate

Cohort study

2(4621)

2.93(-0.29, 6.14)

0.091, 64.9%#

 

0.317,-

Low

Lung Transplantation

      

Total

3(9351)

1.61 (0.50, 2.71)*

0.649, 0.0%

 

1.000, 0.312

Low